Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults: Erratum

doi: 10.1097/QAD.0b013e32835ed8c3
Errata

There is an error in Fig. 2 of the article ‘Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults.’ by Sherene M. et al. which appeared on pp. 1737–1745 of AIDS, volume 25, issue 14 [1].

In the original figure, the Ctau on the x-axis is incorrect but the correct version can be found in the figure below:

Back to Top | Article Outline

Reference

Figure. No caption a...
1. Min S, Sloan L, DeJesus E, Hawkins T, McCurdy L, Song I, et al. Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults. AIDS 2011; 25:1737–1745.
Copyright © 2013 Wolters Kluwer Health, Inc.